Sexual function in women using Depo- medroxy Progesterone Acetate (DMPA)
Advances in Nursing & Midwifery,
Vol. 24 No. 87 (2015),
16 January 2015
Background and aim: Sexuality is an important aspect of quality of life that affects both physical and
psychological aspects. Sexual relationship is central to quality of women’s life, and reflects her psychosocial
and life aspects. Different factors such as health, emotional problems, stress, and hormones affect sexual
function. Some reports reveal the effect of hormones, and conversely, some report lack of effect. This study
aimed to asses sexual function of women using DMPA presenting to health centers affiliated to Shahid
Beheshti University of Medical Sciences in Tehran , Iran in 2013
Methods and material : This descriptive study was conducted on 120 women in health centers in Tehran,
Iran. They were selected by multistage sampling. A questionnaire completed by interviewing was used for
data collecting. 3 parts were included in the questionnaire: demographic characteristic, and Female Sexual
Function Index (FSFI). Data was analyzed by SPSS 16 and Different statistical tests were used. (P<0. 05)
Result: Mean age of women was 28. 63±7. 16 years. Women use DMPA had favorite sexual function (60.
8%). Logistic regression showed women with regular menstruation had favorite sexual function than others
(P<0. 05) .
Conclusion: Menstrual patterns was significantly associated with sexual function.While introducing
hormonal contraceptive methods, health workers should emphasize their adverse effects such as menstrual
patterns on sexual function.
Key word: Sexual function, Depo-medroxy Progesterone Acetate, Prevalence, Iran.
- Sexual function
- Depo-medroxy Progesterone Acetate
How to Cite
-Aliakbari Dehkordi M (2010) [Relationship between women sexual function and marital adjustment].
Journal of Behavioral Sciences. 4 (3) 11-12. (Persian)
-Asghari Roodsari A, Khademi A, Hamed E A, Tabatabaiifar S L and Alleyassin A (2005) Female sexual
dysfunction in married medical students. McGill Journal of Medicine. 8 (2) 104 .
-Bancroft J, Loftus J and Long J S (2003) Distress about sex: A national survey of women in heterosexual
relationships. Archives of sexual behavior. 32 (3) 193-208 .
-Basson R (2005) Women's sexual dysfunction: revised and expanded definitions. Canadian Medical
Association Journal. 172 (10) 1327-1333 .
-Berek J S and Novak E (2012) Berek & Novak's gynecology. 15th edition. Philadelphia, Wolters Kluwer
Health/Lippincott Williams & Wilkins).
-Biddle A K, West S L, D'Aloisio A A, Wheeler S B, Borisov N N and Thorp J (2009) Hypoactive sexual
desire disorder in postmenopausal women: quality of life and health burden. Value in health : the journal
of the International Society for Pharmacoeconomics and Outcomes Research. 12 (5) 763-72 .
-Cayan S, Akbay E, Bozlu M, Canpolat B, lent u, Acar D, Ulusoy E and ment u (2003) The prevalence of
female sexual dysfunction and potential risk factors that may impair sexual function in Turkish women.
Urologia internationalis. 72 (1) 52-57 .
-Clayton A H (2003) Sexual function and dysfunction in women. The Psychiatric clinics of North
America. 26 (3) 673-82 .
-Cunningham F G and Williams J W (2010) Williams obstetrics. 23rd ed. / [edited by] F. Gary
Cunningham ... [et al.]. edition. New York, McGraw-Hill Medical ; London : McGraw-Hill [distributor]).
-Davis A R and Castano P M (2004) Oral contraceptives and libido in women. Annual review of sex
research. 15 297-320 .
-de Cetina T E C, Luna M O, Canto J A C and Bassol S (2004) Menstrual pattern and lipid profiles during
use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive
injections. Contraception. 69 (2) 115-119 .
-de Mello Jacobucci M S B, Guazzelli C A F, Barbieri M, Araújo F F and Moron A F (2006) Bleeding
patterns of adolescents using a combination contraceptive injection for 1 year. Contraception. 73 (6) 594-
-Fathizadeh N, Abdi F and Savabi M (2011) A comparative study on satisfaction from hormonal
contraceptives: depot medroxyprogesterone acetate (DMPA), Cyclofem and LD. Iranian journal of
nursing and midwifery research. 16 (4) 304-8 .
-Foroutan S and Jadid Milani M (2008) [The prevalence of sexual dysfunction among divorce requested].
Daneshvar Medicine. 16 (78) 39-44. (Persian(
-Gelder M G, Mayou R, Gelder M G C O t o p and Geddes J M D (1999) Oxford core texts psychiatry. N.
Pourafkary. 2nd ed. / Michael Gelder, Richard Mayou, John Geddes. edition. Tehran, Golban Medical
-Gold M A and Bachrach L K (2004) Contraceptive use in teens: A threat to bone health? Journal of
Adolescent Health. 35 (6) 427-429 .
-Goldstein J, Cushman M, Badger G J and Johnson J V (2007) Effect of depomedroxyprogesterone acetate
on coagulation parameter: a pilot study. Fertility and sterility. 87 (6) 1267-70 .
-Gonzalez M, Viafara G, Caba F and Molina E (2004) Sexual function, menopause and hormone
replacement therapy (HRT). Maturitas. 48 (4) 411-20 .
-Goshtasbi A, Vahdaninia M A S, Rahimi Foroushani A and Mohammadi A (2008) [Reproductive
correlates of female sexual dysfunctions in kohgilouyeh- boyerahmad province: A population-based
study]. Payesh Journal. 7 (1) 67-73. (Persian)
-Hassanzadeh R, Kamalifard M, Bazargani H and Charandabi S (2012) Comparison of Continuation Rates
and Reasons of Discontinuation for Cyclofem and Depot-medroxyprogesterone acetate in Rural Areas of
East Azerbaijan Province, Iran. Journal of Family and Reproductive Health. 6 (1) 23-27 .
-Hubacher D, Lopez L, Steiner M J and Dorflinger L (2009) Menstrual pattern changes from
levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons.
Contraception. 80 (2) 113-118 .
-Jahanfar S and Molaeenezhad M (2005) [Textbook of sexual disorders]. 2nd edition. Tehran, Bizheh &
-Jha S and Thakar R Female sexual dysfunction. European Journal of Obstetrics and Gynecology and
Reproductive Biology. 153 (2) 117-123 .
-Jiann B P, Su C C, Yu C C, Wu T T and Huang J K (2009) Risk factors for individual domains of female
sexual function. The journal of sexual medicine. 6 (12) 3364-3375 .
-Korda J B (2008) [Female sexual dysfunction]. Der Urologe. 47 (1) 77-89; quiz 90-1. (German)
-Lewis R W, Fugl‐Meyer K S, Bosch R, Fugl‐Meyer A R, Laumann E O, Lizza E and Martin‐Morales A
(2004) Epidemiology/risk factors of sexual dysfunction. The journal of sexual medicine. 1 (1) 35-39 .
-Littlejohn K E (2012) Hormonal contraceptive use and discontinuation because of dissatisfaction:
differences by race and education. Demography. 49 (4) 1433-1452 .
-Nik-Azin A, Nainian M R, Zamani M, Bavojdan M R, Bavojdan M R and Motlagh M J (2013) Evaluation
of sexual function, quality of life, and mental and physical health in pregnant women. Journal of family &
reproductive health. 7 (4) 171-6 .
-Ojanlatva A, Mäkinen J, Helenius H, Korkeila K, Sundell J and Rautava P (2006) Sexual activity and
perceived health among Finnish middle-aged women. Health and quality of life outcomes. 4 .٢٩ (١)
-Oksuz E and Malhan S (2006) Prevalence and risk factors for female sexual dysfunction in Turkish
women. The Journal of urology. 175 (2) 654-8; discussion 658 .
-Panzer C, Wise S, Fantini G, Kang D, Munarriz R, Guay A and Goldstein I (2006) Impact of oral
contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women
with sexual dysfunction. Journal of Sexual Medicine. 3 (1) 104-13 .
-Ponholzer A, Roehlich M, Racz U, Temml C and Madersbacher S (2005) Female sexual dysfunction in a
healthy Austrian cohort: prevalence and risk factors. European urology. 47 (3) 366-74; discussion 374-5 .
-Prabhakaran S (2008) Self-administration of injectable contraceptives. Contraception. 77 (5) 315-7 .
-Rafatmah A, Nazari M A and Nasrollahi B (2011) The relationship between sexual variety-seeking and
marital satisfaction among available couples. Procedia-Social and Behavioral Sciences. 30 1381-1384 .
-Rahmani A, Safavi S, Jafarpoor M and Merghati-Khoei E A (2010) [The relation of sexual satisfaction
and demographic factors]. Iran Journal of Nursing. 23 (66) 14-22. (Persian(
-Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D and D'Agostino R, Jr.
(2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the
assessment of female sexual function. Journal of sex & marital therapy. 26 (2) 191-208 .
-Rowland D and Incrocci L (2008) Handbook of sexual and gender identity disorders. edition. Hoboken,
N.J., John Wiley & Sons).
-Sadock B J, Kaplan H I and Sadock V A (2007) Kaplan & Sadock's synopsis of psychiatry : behavioral
sciences/clinical psychiatry. 10th ed. / Benjamin James Sadock, Virginia Alcott Sadock. edition.
Philadelphia ; London, Wolter Kluwer/Lippincott Williams & Wilkins).
-Schaffir J A, Isley M M and Woodward M (2010) Oral contraceptives vs injectable progestin in their
effect on sexual behavior. American journal of obstetrics and gynecology. 203 (6) 545. e1-545. e5 .
-Segraves R T (2002) Female sexual disorders: psychiatric aspects. Canadian journal of psychiatry. Revue
canadienne de psychiatrie. 47 (5) 419-25 .
-Sepahriyan F (2001) [Preliminary study of factors on Divorce]. Journal of Mental Health. 6 17-29.
-Veisi F and Zangeneh M (2013) Comparison of Two Different Injectable Contraceptive Methods: Depomedroxy
Progesterone Acetate (DMPA) and Cyclofem. Journal of family & reproductive health. 7 (3)
-Wanyonyi S Z, Stones W R and Sequeira E (2011) Health-related quality of life changes among users of
depot medroxyprogesterone acetate for contraception. Contraception. 84 (5) e17-e22 .
-Witting K, Santtila P, Jern P, Varjonen M, Wager I, Höglund M, Johansson A, Vikström N and
Sandnabba N K (2008) Evaluation of the Female Sexual Function Index in a population based sample
from Finland. Archives of sexual behavior. 37 (6) 912-924 .
- Abstract Viewed: 513 times
- PDF Downloaded: 5070 times